U.S. markets close in 2 hours 8 minutes
  • S&P 500

    4,226.02
    -6.58 (-0.16%)
     
  • Dow 30

    35,026.27
    +248.51 (+0.71%)
     
  • Nasdaq

    13,530.50
    -221.73 (-1.61%)
     
  • Russell 2000

    2,248.92
    -22.71 (-1.00%)
     
  • Crude Oil

    64.94
    +0.04 (+0.06%)
     
  • Gold

    1,836.80
    +5.50 (+0.30%)
     
  • Silver

    27.49
    +0.01 (+0.03%)
     
  • EUR/USD

    1.2161
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.5910
    +0.0140 (+0.89%)
     
  • GBP/USD

    1.4142
    +0.0153 (+1.09%)
     
  • USD/JPY

    108.8590
    +0.2770 (+0.26%)
     
  • BTC-USD

    57,466.18
    +92.39 (+0.16%)
     
  • CMC Crypto 200

    1,533.28
    -28.02 (-1.79%)
     
  • FTSE 100

    7,123.68
    -6.03 (-0.08%)
     
  • Nikkei 225

    29,518.34
    +160.52 (+0.55%)
     

Why Earnings Season Could Be Great for TFF Pharmaceuticals (TFFP)

  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Investors are always looking for stocks that are poised to beat at earnings season and TFF Pharmaceuticals, Inc. TFFP may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because TFF Pharmaceuticals is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for TFFP in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 22 cents per share for TFFP, compared to a broader Zacks Consensus Estimate of a loss of 23 cents per share. This suggests that analysts have very recently bumped up their estimates for TFFP, giving the stock a Zacks Earnings ESP of +5.71% heading into earnings season.

TFF Pharmaceuticals, Inc. Price and EPS Surprise

TFF Pharmaceuticals, Inc. Price and EPS Surprise
TFF Pharmaceuticals, Inc. Price and EPS Surprise

TFF Pharmaceuticals, Inc. price-eps-surprise | TFF Pharmaceuticals, Inc. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that TFFP has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for TFF Pharmaceuticals, and that a beat might be in the cards for the upcoming report.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

TFF Pharmaceuticals, Inc. (TFFP) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research